Pig islets for clinical islet xenotransplantation

Area of Science:

• Xenotransplantation research
• Endocrinology
• Cellular transplantation

Background:

• Allogeneic islet transplantation is limited by donor organ scarcity and suboptimal implantation sites.
• Alternative sources of insulin-producing cells are crucial for diabetes treatment.
• Pigs offer a potential source for insulin-producing cells.

Purpose of the Study:

• To review current knowledge on pig islet transplantation in primates.
• To identify challenges and opportunities in pig islet xenotransplantation.
• To guide the selection of an 'ideal' pig donor for clinical use.

Main Methods:

• Review of recent preclinical studies on pig islet transplantation in primate models.
• Analysis of functional outcomes and survival of transplanted pig islets.
• Evaluation of factors influencing xenograft success.

Main Results:

• Pig islets have demonstrated functionality in diabetic primate recipients for at least six months.
• Despite the species barrier, successful engraftment and function have been observed.
• Preclinical data supports the potential of pig islets for diabetes therapy.

Conclusions:

• Pig islet xenotransplantation is a viable strategy to address donor organ shortages.
• Overcoming the species barrier is key to translating preclinical success to clinical practice.
• Selecting an appropriate pig donor is critical for the future of clinical pig islet xenotransplantation.